Insider at Issuer (NASDAQ: CRWD) files Form 144 to sell 3,000 shares
Rhea-AI Filing Summary
An insider has filed a notice of proposed sale of 3,000 shares of Class A common stock of the issuer. The shares are to be sold through J.P. Morgan Securities LLC on the NASDAQ, with an approximate sale date of 01/15/2026. The filing lists an aggregate market value of 1,382,100 for the planned sale and notes that there were 252,098,440 shares outstanding of this class of stock.
The shares being sold were acquired on 08/11/2020 through an incentive stock option (ISO) exercise from the issuer, with the purchase price paid in cash on the same date. By signing the notice, the seller represents that they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does the CRWD Form 144 filing disclose?
The filing discloses that an insider plans to sell 3,000 shares of Class A common stock of the issuer, with an aggregate market value of 1,382,100, on the NASDAQ through J.P. Morgan Securities LLC around 01/15/2026.
How many CRWD shares are planned to be sold and what is their value?
The planned sale covers 3,000 shares of Class A common stock with an aggregate market value of 1,382,100, as reported in the Form 144.
How were the CRWD shares in this Form 144 originally acquired?
The 3,000 shares were acquired on 08/11/2020 via an ISO (incentive stock option) exercise from the issuer, with the purchase price paid in cash on that date.
On which exchange and through which broker will the CRWD shares be sold?
The shares are intended to be sold on the NASDAQ through J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.
How many CRWD shares were outstanding according to this Form 144?
The notice states that there were 252,098,440 shares of the relevant class of common stock outstanding at the time referenced in the form.
What representation does the seller make in this CRWD Form 144?
By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.